Registry study for the evaluation of incidence and risk factors of vasoplegia in Freiburg

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021045

Enrollment

100

Registered

2020-07-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vasoplegia

Interventions

Group 1: This study is a non-interventional study. It is a registry study to collect information about patients with vasoplegia (see inclusion criteria).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Included will be all patients at any one time within the first 48 hours after admission to the intensive care unit, which meet a combination of at least two of the definition criteria below Definition criteria: • MAD <60 mmHg • HI = 2.5 l / min / m² • SVR <800 dynes x s / cm² • Noradrenaline requirement = 0.2 µg / kg x min lasting for at least 12 hours

Exclusion criteria

Exclusion criteria: Excluded will be all patients with one of the following - positive detection of germs in at least one blood culture during the observation period, - known sepsis, - hypovolaemia and / or - known vascular barrier disorder

Design outcomes

Primary

Measure	Time frame
This study is a registry study to evaluate incidence and risk factors of vasoplegia. A classical description of a primary outcome is not applicable.	—

Countries

Germany

Contacts

Public ContactGeorg Trummer

Universitäts-Herzzentrum Freiburg - Bad Krozingen

georg.trummer@universitaets-herzzentrum.de076127088888

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026